UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...

Dr. Apathy serves as an assistant professor of health policy and management at the University of Maryland School of Public Health in College Park, Maryland. He is also an affiliated research scientist ...

In a clinical guideline issued by the American College of Gastroenterology and published in the January issue of the American ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...

Pregnancy comes with unique health risks and considerations, but pregnant people also continue to experience the same health ...

NORMAN LEPOR CARDIOLOGY Director National Heart Institute Norman Lepor has distinguished himself as an academic leader ...

A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood ...

Breanna Krueger, an associate professor in the Division of Communication Disorders within the University of Wyoming’s College ...

Weather-related disasters may dominate news coverage related to climate change, but hospitals are also seeing more patients who require care due to extreme temperatures, drought, poor air quality, and ...

Vedanta Biosciences, a late clinical-stage company developing defined bacterial consortia as oral therapies for gastrointestinal diseases, today announced the publication of additional results from ...